Abstract
Background
Aerobic vaginitis (AV) is a newly defined clinical entity that is distinct from candidiasis, trichomoniasis and bacterial vaginosis (BV). Because of the poor recognition of AV, this condition can lead to treatment failures and is associated with severe complications, such as pelvic inflammatory disease, infertility, preterm birth and foetal infections.
Objective
This review describes the diagnosis and treatment of AV and the relationship between AV and pregnancy.
Results
The characteristics of AV include severely depressed levels of lactobacilli, increased levels of aerobic bacteria and an inflamed vagina. The diagnosis is made by microscopy on wet mounts of fresh vaginal fluid, and some distinct clinical features are recognized. Vaginal suppositories that contain kanamycin or clindamycin have shown curative effects in nonpregnant women. Additionally, the application of topical probiotics can restore the vaginal flora and reduce the recurrence of AV. Clindamycin vaginal suppositories and probiotics may be a better choice for gravida with AV than metronidazole. AV requires prompt attention, and the early diagnosis and treatment of AV during pregnancy significantly improves perinatal outcomes.
Conclusion
Further research is needed to define the pathogenesis, diagnostic criteria and standard treatment guidelines for AV.
Similar content being viewed by others
References
Donati L, Di Vico A, Nucci M, Quagliozzi L, Spagnuolo T, Labianca A, Bracaglia M, Ianniello F, Caruso A, Paradisi G (2010) Vaginal microbial flora and outcome of pregnancy. Arch Gynecol Obstet 281:589–600
Tansarli GS, Kostaras EK, Athanasiou S, Falagas ME (2013) Prevalence and treatment of aerobic vaginitis among non-pregnant women: evaluation of the evidence for an underestimated clinical entity. Eur J Clin Microbiol Infect Dis 32:977–984
Pereira N, Edlind TD, Schlievert PM, Nyirjesy P (2013) Vaginal toxic shock reaction triggering desquamative inflammatory vaginitis. J Low Genit Tract Dis 17:88–91
MacPhee RA, Miller WL, Gloor GB, McCormick JK, Hammond JA, Burton JP, Reid G (2013) Influence of the vaginal microbiota on toxic shock syndrome toxin 1 production by Staphylococcus aureus. Appl Environ Microbiol 79:1835–1842
Donders GG, Vereecken A, Bosmans E, Dekeersmaecker A, Salembier G, Spitz B (2002) Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG 109:34–43
Scheffey LC, Rakoff AE, Lang WR (1956) An unusual case of exudative vaginitis (hydrorrhea vaginalis) treated with local hydrocortisone. Am J Obstet Gynecol 72:208–211
Gray LA, Barnes ML (1965) Vaginitis in women, diagnosis and treatment. Am J Obstet Gynecol 92:125–136
Gardner HL (1968) Desquamative inflammatory vaginitis: a newly defined entity. Am J Obstet Gynecol 102:1102–1105
Paavonen J (1996) Desquamative inflammatory vaginitis. Infect Dis Obstet Gynecol 4:257
Fan AP, Xue FX (2010) Clinical characteristics of aerobic vaginitis and its mixed infections.]. Zhonghua Fu Chan Ke Za Zhi 45:904–908
Donders GG, Van Calsteren K, Bellen G, Reybrouck R, Van den Bosch T, Riphagen I, Van Lierde S (2009) Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy. BJOG 116:1315–1324
Gondo F, Da SM, Polettini J, Tristao AR, Peracoli JC, Witkin SS, Rudge MV (2011) Vaginal flora alterations and clinical symptoms in low-risk pregnant women. Gynecol Obstet Invest 71:158–162
Zodzika J, Rezeberga D, Jermakova I, Vasina O, Vedmedovska N, Donders G (2011) Factors related to elevated vaginal pH in the first trimester of pregnancy. Acta Obstet Gynecol Scand 90:41–46
Tempera G, Abbadessa G, Bonfiglio G, Cammarata E, Cianci A, Corsello S, Raimondi A, Ettore G, Nicolosi D, Furneri PM (2006) Topical kanamycin: an effective therapeutic option in aerobic vaginitis. J Chemother 18:409–414
Marconi C, Donders GG, Bellen G, Brown DR, Parada CM, Silva MG (2013) Sialidase activity in aerobic vaginitis is equal to levels during bacterial vaginosis. Eur J Obstet Gynecol Reprod Biol 167:205–209
Donders GG, Vereecken A, Bosmans E, Spitz B (2003) Vaginal cytokines in normal pregnancy. Am J Obstet Gynecol 189:1433–1438
Donders G, Bellen G, Rezeberga D (2011) Aerobic vaginitis in pregnancy. BJOG 118:1163–1170
Sobel JD (1994) Desquamative inflammatory vaginitis: a new subgroup of purulent vaginitis responsive to topical 2 % clindamycin therapy. Am J Obstet Gynecol 171:1215–1220
Curzik D, Drazancic A, Hrgovic Z (2001) Nonspecific aerobic vaginitis and pregnancy. Fetal Diagn Ther 16:187–192
Von Gruenigen VE, Coleman RL, Li AJ, Heard MC, Miller DS, Hemsell DL (2000) Bacteriology and treatment of malodorous lower reproductive tract in gynecologic cancer patients. Obstet Gynecol 96:23–27
Razzak MS, Al-Charrakh AH, Al-Greitty BH (2011) Relationship between lactobacilli and opportunistic bacterial pathogens associated with vaginitis. N Am J Med Sci 3:185–192
Otuonye NM, Odunukwe NN, Idigbe EO, Imosemi OD, Smith SI, Chigbo RC, Bamidele M, Oparaugo CT, Mafe AG, Musa AZ (2004) Aetiological agents of vaginitis in Nigerian women. Br J Biomed Sci 61:175–178
Iavazzo C, Vogiatzi C, Falagas ME (2008) A retrospective analysis of isolates from patients with vaginitis in a private Greek obstetric/gynecological hospital (2003–2006). Med Sci Monit 14:R228–R231
Hammann R, Kronibus A, Lang N, Werner H (1987) Quantitative studies on the vaginal flora of asymptomatic women and patients with vaginitis and vaginosis. Zentralbl Bakteriol Mikrobiol Hyg A 265:451–461
Dykhuizen RS, Harvey G, Gould IM (1995) The high vaginal swab in general practice: clinical correlates of possible pathogens. Fam Pract 12:155–158
Tempera G, Furneri PM (2010) Management of aerobic vaginitis. Gynecol Obstet Invest 70:244–249
Reid G, Bruce AW, McGroarty JA, Cheng KJ, Costerton JW (1990) Is there a role for lactobacilli in prevention of urogenital and intestinal infections? Clin Microbiol Rev 3:335–344
Pelisse M (1989) The vulvo-vaginal-gingival syndrome. A new form of erosive lichen planus. Int J Dermatol 28:381–384
Hewitt J, Pelisse M, Lessana-Leibowitch M, Sedel D, Fischesser D, Moyal-Barracco M, Frances C, Farcet Y (1985) Vulvovaginogingival syndrome. New characteristic grouping of plurimucous erosive lichen planus. Rev Stomatol Chir Maxillofac 86:57–65
Edwards L, Friedrich EJ (1988) Desquamative vaginitis: lichen planus in disguise. Obstet Gynecol 71:832–836
Ridley CM (1990) Chronic erosive vulval disease. Clin Exp Dermatol 15:245–252
Edwards L (1992) Desquamative vulvitis. Dermatol Clin 10:325–337
Peacocke M, Djurkinak E, Thys-Jacobs S (2008) Treatment of desquamative inflammatory vaginitis with vitamin D: a case report. Cutis 81:75–78
Peacocke M, Djurkinak E, Tsou HC, Thys-Jacobs S (2010) Desquamative inflammatory vaginitis as a manifestation of vitamin D deficiency associated with Crohn disease: case reports and review of the literature. Cutis 86:39–46
Donders GG (2007) Definition and classification of abnormal vaginal flora. Best Pract Res Clin Obstet Gynaecol 21:355–373
Donders GG (1999) Microscopy of the bacterial flora on fresh vaginal smears. Infect Dis Obstet Gynecol 7:126–127
Donders G, De Wet HG, Hooft P, Desmyter J (1993) Lactobacilli in Papanicolaou smears, genital infections, and pregnancy. Am J Perinatol 10:358–361
Fan A, Yue Y, Geng N, Zhang H, Wang Y, Xue F (2013) Aerobic vaginitis and mixed infections: comparison of clinical and laboratory findings. Arch Gynecol Obstet 287:329–335
Frey TB (2011) Antimicrobial topical agents used in the vagina. Curr Probl Dermatol 40:36–47
Tempera G, Bonfiglio G, Cammarata E, Corsello S, Cianci A (2004) Microbiological/clinical characteristics and validation of topical therapy with kanamycin in aerobic vaginitis: a pilot study. Int J Antimicrob Agents 24:85–88
Sobel JD, Reichman O, Misra D, Yoo W (2011) Prognosis and treatment of desquamative inflammatory vaginitis. Obstet Gynecol 117:850–855
Li J, McCormick J, Bocking A, Reid G (2012) Importance of vaginal microbes in reproductive health. Reprod Sci 19:235–242
Boris S, Suarez JE, Vazquez F, Barbes C (1998) Adherence of human vaginal lactobacilli to vaginal epithelial cells and interaction with uropathogens. Infect Immun 66:1985–1989
Ozkinay E, Terek MC, Yayci M, Kaiser R, Grob P, Tuncay G (2005) The effectiveness of live lactobacilli in combination with low dose oestriol (Gynoflor) to restore the vaginal flora after treatment of vaginal infections. BJOG 112:234–240
Donders GG, Van Bulck B, Van de Walle P, Kaiser RR, Pohlig G, Gonser S, Graf F (2010) Effect of lyophilized lactobacilli and 0.03 mg estriol (Gynoflor(R)) on vaginitis and vaginosis with disrupted vaginal microflora: a multicenter, randomized, single-blind, active-controlled pilot study. Gynecol Obstet Invest 70:264–272
Al-Kadri HM, Bamuhair SS, Johani SM, Al-Buriki NA, Tamim HM (2013) Maternal and neonatal risk factors for early-onset group B streptococcal disease: a case control study. Int J Womens Health 5:729–735
Mario MJ, Valenzuela I, Vasquez AE, Illanes SE (2013) Prevention of early-onset neonatal group B Streptococcal disease. Rev Obstet Gynecol 6:63–68
Javanmanesh F, Eshraghi N (2013) Prevalence of positive recto-vaginal culture for Group B streptococcus in pregnant women at 35–37 weeks of gestation. Med J Islam Repub Iran 27:7–11
Jones N, Oliver K, Jones Y, Haines A, Crook D (2006) Carriage of group B streptococcus in pregnant women from Oxford, UK. J Clin Pathol 59:363–366
Chan GJ, Baqui AH, Modak JK, Murillo-Chaves A, Mahmud AA, Boyd TK, Black RE, Saha SK (2013) Early-onset neonatal sepsis in Dhaka, Bangladesh: risk associated with maternal bacterial colonisation and chorioamnionitis. Trop Med Int Health 18:1057–1064
Chaudhry BY, Akhtar N, Balouch AH (2010) Vaginal carriage rate of group B Streptococcus in pregnant women and its transmission to neonates. J Ayub Med Coll Abbottabad 22:167–170
Carey JC, Klebanoff MA (2005) Is a change in the vaginal flora associated with an increased risk of preterm birth? Am J Obstet Gynecol 192:1341–1346
Larsson PG, Fahraeus L, Carlsson B, Jakobsson T, Forsum U (2006) Late miscarriage and preterm birth after treatment with clindamycin: a randomised consent design study according to Zelen. BJOG 113:629–637
Acknowledgments
This study was supported by the Natural Science Fund of China (No. 81471419) and partially supported by grants from the Science Foundation of Tianjin (2013ky01).
Conflict of interest
The authors declare that they have no competing interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Han, C., Wu, W., Fan, A. et al. Diagnostic and therapeutic advancements for aerobic vaginitis. Arch Gynecol Obstet 291, 251–257 (2015). https://doi.org/10.1007/s00404-014-3525-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-014-3525-9